Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation

Bing Yao, Qiangbing Yang, Christian J B Snijders Blok, Mark A Daniels, Pieter A Doevendans, Raymond Schiffelers, Joost P G Sluijter, Zhiyong Lei*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Prime editing (PE) represents a transformative genome-editing technology and enables precise insertions, deletions, and base substitutions without introducing double-strand breaks, thereby reducing undesired indels and off-target effects. Despite advancements in enhanced prime editors and optimized prime editing guide RNAs (pegRNAs), designing effective pegRNAs remains a major challenge. The phospholamban (PLN) R14del mutation is associated with cardiomyopathies, making it a crucial target for precise gene-editing strategies. In this study, we explored pegRNA features that contribute to high editing efficiency using the FluoPEER.PLN R14del reporter cell line. Through systematic screening, we identified three pegRNAs with significantly enhanced editing efficiency. Our findings underscore the importance of pegRNA secondary structure and stability in optimizing prime editing, providing valuable insights into precise gene correction strategies.

Original languageEnglish
Pages (from-to)2543-2554
Number of pages12
JournalFEBS letters
Volume599
Issue number17
Early online date24 Jun 2025
DOIs
Publication statusPublished - Sept 2025

Keywords

  • PLN R14del mutation
  • Phospholamban
  • gene therapy
  • pegRNA optimization
  • prime editing

Fingerprint

Dive into the research topics of 'Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation'. Together they form a unique fingerprint.

Cite this